Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2. This is a minor metadata/UI update with no impact on study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 has been added, while the previous funding-status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded a global site notice about a lapse in government funding and updated operation status with a link to opm.gov; the notice states the NIH Clinical Center is open. The site revision was updated from v3.4.0 to v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check45 days agoChange DetectedAdded a Show glossary option and QC/version metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedA new footer revision tag 'Revision: v3.3.3' appears, and the 'HHS Vulnerability Disclosure' link and the prior 'Revision: v3.3.2' tag were removed.SummaryDifference0.1%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.